Human Leukocyte Antigen (HLA) part 23

hla protein 1


Recently, additional serologic methods have been developed  that do not have lymphocytotoxicity as an end point. One is based on flow cytometric analysis of alloantibodies binding to panel donor lymphocytes or beads coated with different HLA molecules. Serum screening is also now being done with an ELISA assay that uses solubilized HLA antigens immobilized on a solid surface.


About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s